Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 511
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Dexacortone vet 0.5 mg V/DCP/17/0051 Le Vet Beheer B.V., Nīderlande QH02AB02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Dexamethasone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Genera d.d., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0051-01 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-02 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-03 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-04 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-05 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-06 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-07 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-08 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-09 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-10 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Dexacortone vet 2 mg V/DCP/17/0052 Le Vet Beheer B.V., Nīderlande QH02AB02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Dexamethasone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0052-01 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-02 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-03 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-05 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-06 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-07 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-08 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-09 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-10 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-11 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Cepesedan 10 mg/ml V/MRP/07/1690 CP-Pharma Handelsgesellschaft GmbH, Vācija QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1690-01 10 mg/ml 1 Stikla pudelīte, 5 ml -
V/MRP/07/1690-02 10 mg/ml 5 Stikla pudelīte, 5 ml -
V/MRP/07/1690-03 10 mg/ml 1 Stikla pudelīte, 20 ml -
V/MRP/07/1690-04 10 mg/ml 5 Stikla pudelīte, 20 ml -
Advantage 40 mg V/NRP/01/1363 Elanco Animal Health GmbH, Vācija QP53AX17 small cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bayer HealthCare AG, Vācija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI” (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1363-01 40 mg 2 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-02 40 mg 3 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-03 40 mg 4 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-04 40 mg 6 Polipropilēna pipete, 0,4 ml -
Triquest 333 mg/ml + 67 mg/ml - V/DCP/24/0058 Alfasan Nederland BV, Nīderlande QJ01EW10 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (14-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0058-01 1 ABPE pudele, 225 ml -
V/DCP/24/0058-02 1 ABPE pudele, 450 ml -
V/DCP/24/0058-03 1 ABPE pudele, 90 ml -
Fiprotec 50 mg V/DCP/14/0019 Beaphar B.V., Nīderlande QP53AX15 cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0019-01 50 mg 1 Pipete, 1 deva -
V/DCP/14/0019-02 50 mg 2 Pipete, 1 deva -
V/DCP/14/0019-03 50 mg 3 Pipete, 1 deva -
V/DCP/14/0019-04 50 mg 6 Pipete, 1 deva -
V/DCP/14/0019-07 50 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-08 50 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-09 50 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-10 50 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-11 50 mg 6 Pipete alumīnija blisterī, 1 deva -
Bovaclox DC - V/NRP/98/0802 Norbrook Laboratories (Ireland) Limited, Īrija QJ51RC26 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cloxacillin benzathine, Ampicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0802-01 24 Injektors, 1 deva -
V/NRP/98/0802-02 120 Injektors, 1 deva -
V/NRP/98/0802-03 120 Injektors, 1 deva -
Dophexine 20 mg/g V/DCP/20/0047 Dopharma Research B.V., Nīderlande QR05CB02 cattle; pigs; ducks; turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water/ milk
International name (active substance): Bromhexine hydrohloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0047-01 20 mg/g 1 Polipropilēna konteiners, 1 kg -
V/DCP/20/0047-02 20 mg/g 1 Kompozītmateriāla kārba, 1 kg -
V/DCP/20/0047-03 20 mg/g 1 Polipropilēna spainis, 1 kg -
V/DCP/20/0047-04 20 mg/g 1 Polipropilēna spainis, 2,5 kg -
V/DCP/20/0047-05 20 mg/g 1 Polipropilēna spainis, 5 kg -
LV Intermectin 10 mg/ml V/NRP/12/0041 Interchemie Werken De Adelaar Eesti AS, Igaunija QP54AA01 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0041-01 10 mg/ml 1 Stikla pudele ar Al vāciņu, 100 ml -
V/NRP/12/0041-02 10 mg/ml 1 Stikla pudele ar Al vāciņu, 50 ml -
V/NRP/12/0041-03 10 mg/ml 1 Stikla pudele ar Al vāciņu, 10 ml -
V/NRP/12/0041-04 10 mg/ml 1 Stikla pudele ar Al vāciņu, 500 ml -
V/NRP/12/0041-05 10 mg/ml 1 PET pudele, 50 ml -
V/NRP/12/0041-06 10 mg/ml 1 PET pudele, 100 ml -
V/NRP/12/0041-07 10 mg/ml 1 PET pudele, 10 ml -
V/NRP/12/0041-08 10 mg/ml 1 PET pudele, 500 ml -
K1 KEYVIT 50 mg V/DCP/21/0064 NEXTMUNE ITALY S.R.L., Itālija QB02BA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): PHYTOMENADIONE
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0064-01 50 mg 1 Blisteris, 7 tablete -
V/DCP/21/0064-02 50 mg 2 Blisteris, 7 tablete -
V/DCP/21/0064-03 50 mg 3 Blisteris, 7 tablete -
V/DCP/21/0064-04 50 mg 4 Blisteris, 7 tablete -
V/DCP/21/0064-05 50 mg 5 Blisteris, 7 tablete -
V/DCP/21/0064-06 50 mg 12 Blisteris, 7 tablete -
Atonyl 1.5 mg/ml V/DCP/19/0067 Cenavisa S.L, Spānija QN07AA01 cattle; sheep; goats; horses

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Neostigmine methylsulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0067-01 1,5 mg/ml 1 Stikla flakons, 40 ml -
Alvegesic vet. 10 mg/ml V/MRP/11/0044 V.M.D. n.v., Beļģija QN02AF01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butorphanol tartrate
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Sanochemia Pharmazeutica AG, Austrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (31-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (31-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0044-01 10 mg/ml 1 Stikla flakons, 10 ml -
LidoBel 20 mg/ml V/DCP/18/0037 Bela-pharm GmbH&Co.KG, Vācija QN01BB02 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lidocaine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0037-01 1 Stikla flakons, 100 ml -
V/DCP/18/0037-02 1 Stikla flakons, 250 ml -
V/DCP/18/0037-03 12 Stikla flakons, 100 ml -
V/DCP/18/0037-04 12 Stikla flakons, 250 ml -
BIOSUIS ParvoEry - V/DCP/19/0015 Bioveta, a.s., Čehija QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine parvovirus, inactivated, strain CAPM V198, S-27, Erysipelothrix rhusiopathiae inactivated, serotype 2, strain 2-64
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0015-01 1 Stikla flakons, 10 ml -
V/DCP/19/0015-02 10 Stikla flakons, 10 ml -
V/DCP/19/0015-03 1 Stikla flakons, 50 ml -
V/DCP/19/0015-04 1 Plastmasas flakons, 50 ml -
V/DCP/19/0015-05 1 Stikla flakons, 100 ml -
V/DCP/19/0015-06 1 Plastmasas flakons, 100 ml -
V/DCP/19/0015-07 1 Plastmasas flakons, 250 ml -
Hyogen - V/DCP/15/0017 Ceva Sante Animale', Francija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Mycoplasma hyopneumoniae, strain 2940
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 27-May-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0017-01 1 PET pudele, 50 ml -
V/DCP/15/0017-02 1 PET pudele, 100 ml -
V/DCP/15/0017-03 1 PET pudele, 250 ml -
V/DCP/15/0017-04 5 PET pudele, 50 ml -
V/DCP/15/0017-05 5 PET pudele, 100 ml -
V/DCP/15/0017-06 5 PET pudele, 250 ml -
V/DCP/15/0017-07 1 PET pudele, 200 ml -
V/DCP/15/0017-08 5 PET pudele, 200 ml -
V/DCP/15/0017-09 1 PET pudele, 100 deva -
V/DCP/15/0017-10 5 PET pudele, 100 deva -
Altresyn 4 mg/ml V/MRP/08/1610 Ceva Sante Animale', Francija QG03DX90 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Altrenogest
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 23-Dec-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1610-01 4 mg/ml 1 Flakons, 360 ml -
V/MRP/08/1610-02 4 mg/ml 3 Flakons, 360 ml -
V/MRP/08/1610-03 4 mg/ml 1 Konteiners, 540 ml -
V/MRP/08/1610-04 4 mg/ml 1 Konteiners, 1080 ml -
Vetoryl 20 mg V/SRP/25/0025 Dechra Regulatory B.V., Nīderlande QH02CA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Trilostane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/25/0025-01 1 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-02 3 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-03 5 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-04 6 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-05 10 PA/Al/PVH//Al blisteris, 10 tablete -
Vetoryl 30 mg V/SRP/25/0026 Dechra Regulatory B.V., Nīderlande QH02CA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Trilostane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/25/0026-01 1 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-02 3 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-03 5 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-04 6 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-05 10 PA/Al/PVH blisteris, 10 tablete -
Nextmune - V/DCP/20/0046 Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Live attenuated IBD virus, Serotype 1, strain G-61 (Winterfield 2512)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (27-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0046-01 1 Stikla ampula (5ml), 2000 deva -
V/DCP/20/0046-02 1 Stikla ampula (5ml), 4000 deva -
V/DCP/20/0046-03 1 Stikla ampula (5ml), 8000 deva -
V/DCP/20/0046-04 1 Stikla ampula (2ml), 2000 deva -
V/DCP/20/0046-05 1 Stikla ampula (2ml), 4000 deva -
V/DCP/20/0046-06 1 Maiss (šķīdinātājs), 400 ml -
V/DCP/20/0046-07 1 Maiss (šķīdinātājs), 800 ml -
V/DCP/20/0046-08 1 Maiss (šķīdinātājs), 1000 ml -
V/DCP/20/0046-09 1 Maiss (šķīdinātājs), 1200 ml -
V/DCP/20/0046-10 1 Maiss (šķīdinātājs), 1600 ml -
Frontline Combo Dog S - V/NRP/03/1586 Boehringer Ingelheim Animal Health France SCS , Francija QP53AX65 dogs (under 10kg) Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Boehringer Ingelheim Animal Health France SCS., Francija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1586-02 3 Pipete, 0,67 ml -
V/NRP/03/1586-03 6 Pipete, 0,67 ml -
V/NRP/03/1586-10 1 Pipete, 0,67 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy